The demise of aprotinin: Our share of the blame

被引:10
作者
Sundt, Thoralf M. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Surg, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.jtcvs.2008.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:729 / 731
页数:3
相关论文
共 13 条
[1]   Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial [J].
Alderman, EL ;
Levy, JH ;
Rich, JB ;
Nili, M ;
Vidne, B ;
Schaff, H ;
Uretzky, G ;
Pettersson, G ;
Thiis, JJ ;
Hantler, CB ;
Chaitman, B ;
Nadel, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (05) :716-729
[2]   APROTININ THERAPY FOR REOPERATIVE MYOCARDIAL REVASCULARIZATION - A PLACEBO-CONTROLLED STUDY [J].
COSGROVE, DM ;
HERIC, B ;
LYTLE, BW ;
TAYLOR, PC ;
NOVOA, R ;
GOLDING, LAR ;
STEWART, RW ;
MCCARTHY, PM ;
LOOP, FD .
ANNALS OF THORACIC SURGERY, 1992, 54 (06) :1031-1038
[3]   Stroke after cardiac surgery: A retrospective analysis of the effect of aprotinin dosing regimens [J].
Frumento, RJ ;
O'Malley, CMN ;
Bennett-Guerrero, E .
ANNALS OF THORACIC SURGERY, 2003, 75 (02) :479-483
[4]  
Gilovich T., 1991, How We Know What Isn't So
[5]  
Harmon DC, 2004, CAN J ANAESTH, V51, P1002, DOI 10.1007/BF03018488
[6]   APROTININ FOR CORONARY-BYPASS OPERATIONS - EFFICACY, SAFETY, AND INFLUENCE ON EARLY SAPHENOUS-VEIN GRAFT PATENCY - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
LEMMER, JH ;
STANFORD, W ;
BONNEY, SL ;
BREEN, JF ;
CHOMKA, EV ;
ELDREDGE, WJ ;
HOLT, WW ;
KARP, RB ;
LAUB, GW ;
LIPTON, MJ ;
SCHAFF, HV ;
TATOOLES, CJ ;
RUMBERGER, JA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) :543-553
[7]   Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery [J].
Mangano, Dennis T. ;
Miao, Yinghui ;
Vuylsteke, Alain ;
Tudor, Iulia C. ;
Juneja, Rajiv ;
Filipescu, Daniela ;
Hoeft, Andreas ;
Fontes, Manuel L. ;
Hillel, Zak ;
Ott, Elisabeth ;
Titov, Tatiana ;
Dietzel, Cynthia ;
Levin, Jack .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (05) :471-479
[8]   The risk associated with aprotinin in cardiac surgery [J].
Mangano, DT ;
Tudor, IC ;
Dietzel, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :353-365
[9]   Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass? [J].
Rahman, A ;
Üstünda, B ;
Burma, O ;
Özercan, IH ;
Çekirdekçi, A ;
Bayar, MK .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 18 (05) :583-588
[10]   Cost analysis of aprotinin for coronary artery bypass patients: Analysis of the randomized trials [J].
Smith, PK ;
Datta, SK ;
Muhlbaier, LH ;
Samsa, G ;
Nadel, A ;
Lipscomb, J .
ANNALS OF THORACIC SURGERY, 2004, 77 (02) :635-642